KFA Private Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$527K Buy
455
+3
+0.7% +$3.54K 0.12% 77
2026
Q2
$542K Sell
452
-27
-6% -$27.6K 0.13% 73
2026
Q1
$441K Hold
479
– – 0.11% 93
2025
Q4
$515K Buy
479
+105
+28% +$100K 0.13% 79
2025
Q3
$286K Buy
374
+2
+0.5% +$1.49K 0.08% 112
2025
Q2
$290K Sell
372
-10
-3% -$7.77K 0.09% 106
2025
Q1
$316K Buy
382
+25
+7% +$20.8K 0.11% 80
2024
Q4
$275K Buy
357
+13
+4% +$10.8K 0.12% 73
2024
Q3
$305K Sell
344
-1
-0.3% -$899 0.15% 62
2024
Q2
$312K Buy
345
+69
+25% +$55.2K 0.16% 61
2024
Q1
$215K Buy
+276
New +$196K 0.07% 97

Other funds holding LLY

KFA Private Wealth Group's LLY Position: Q3 2026 in Review

KFA Private Wealth Group increased its Eli Lilly (LLY) stake by 0.66% in Q3 2026, buying an estimated $3.54K and bringing the position to 455 shares worth $527K. The position accounts for 0.12% of the portfolio, ranked #77.

KFA Private Wealth Group first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $542K in Q2 2026. 960 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • KFA Private Wealth Group held 455 shares of Eli Lilly worth $527K as of Q3 2026.
  • KFA Private Wealth Group bought 3 Eli Lilly shares in Q3 2026, an estimated $3.54K.
  • Eli Lilly made up 0.12% of KFA Private Wealth Group's portfolio in Q3 2026, its #77 holding.
  • KFA Private Wealth Group first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
  • KFA Private Wealth Group's Eli Lilly position peaked at $542K in Q2 2026.
  • 960 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on KFA Private Wealth Group's 13F filing for Q3 2026, filed 7 Oct 2026.